| abstract |
A compound having the following structure or a salt thereof is provided:nâ–ˇnUsed to treat or reduce androgen-dependent diseases such as prostate cancer, benign prostatic hyperplasia, polycystic ovarian syndrome, acne, hirsutism, seborrheic dermatitis, androgenetic alopecia, male alopecia, muscle atrophy and weakness, Muscular dystrophy, male hypogonadism, erectile dysfunction, female sexual dysfunction and osteoporosis. It can be formulated with a pharmaceutically acceptable diluent or carrier, or in the form of any pharmaceutical agent. Compositions with other active pharmaceutical agents are also disclosed. |